Home Contact

New Jersey Stem Cell Symposium

Exploring academic and corporate stem cell research in New Jersey

Sponsored by:

Rutgers SCRC, Life Technologies, and the Rutgers Stem Cell IGERT Program

The Fourth Annual New Jersey Stem Cell Symposium

  • Date: September 29, 2010
  • Location: Bridgewater Marriott
  • Time: 10:00 am - 6:00 pm

Co-sponsored by the Rutgers Stem Cell Research Center, Life Technologies, and the Rutgers Stem Cell IGERT Program.

Format: This year's symposium will provide comprehensive oral presentations on selected topics, an interactive poster session, technology workshops, and a panel discussion exploring academic-corporate research partnerships. The program will incorporate the annual Rutgers Stem Cell IGERT student symposium, with IGERT fellow presentations, posters, and a networking event.

The abstract submission period is now closed. Watch soon for the final program!

Follow announcements about the 2010 New Jersey Stem Cell Symposium on Twitter! Use the "hash-tag" #njscsymp10 or this link!

Keynote Speaker: Dr. Marius Wernig of Stanford University

Dr. Marius Wernig

We are honored to have Dr. Marius Wernig of the Institute of Stem Cell Biology and Regenerative Medicine and the Department of Pathology at Stanford University School of Medicine as the keynote speaker for the Fourth Annual New Jersey Stem Cell Symposium. Dr. Wernig is the leader in direct reprogramming of skin cells into neurons without passing through a pluripotent stem cell stage. Working with his postdoctoral mentor, Dr. Rudolf Jaenisch of MIT, Dr. Wernig built a mouse strain with drug-inducible, pluripotency transcription factors to demonstrate that every cell type can be converted to an iPS cell. He is a recipient of the Cozzarelli Prize in Biomedical Sciences for the article "Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease," which describes creating pluripotent cells from an animal and integrating these donor cells back into the animal brain to treat a disease. His interests include inducible pluripotency, tissue reprogramming, and epigenetic regulation during induction of pluripotency.

Panel Discussion: Advantages and Challenges of Corporate-Academic Collaborations

Panel ParticipantsA prominent panel of academic and corporate scientists will discuss their experiences, goals, and recommendations for scientists wishing to establish collaborative projects between academia and industry across traditional boundaries.

  • Dr. Martin Grumet, Panel Chair, Professor, Department of Cell Biology & Neuroscience, W.M. Keck Center for Collaborative Neuroscience, and Director, Rutgers Stem Cell Research Center, Rutgers University
  • Dr. Joachim Kohn, Board of Governors Professor of Chemistry and Chemical Biology, Director, New Jersey Center for Biomaterials, Rutgers University
  • Dr. Alan Harris, Vice President of Regenerative Medicine, Drug Development and Regulatory Affairs, Neostem, Inc.
  • Dr. Rodney Turner, Senior Director, Corporate Business Development, Life Technologies


IGERT Plenary Speaker Announced

Dr. Gordana Vunjak-Novakovic

We are pleased to announce that Gordana Vunjak-Novakovic, Ph.D, Professor, Department of Biomedical Engineering; and Director, Laboratory for Stem Cells and Tissue Engineering at Columbia University will be presenting at the upcoming 4th Annual NJ Stem Cell Research Symposium. Dr. Vunjak-Novakovic obtained a Ph.D. degree in chemical engineering at the University of Belgrade, in her homeland of Serbia. Upon moving to the USA, Dr. Vunjak-Novakovic spent twelve years at the Harvard-MIT Division for Health Sciences and Technology. As a Fulbright Fellow, she became fascinated by the concept of tissue engineering, and emerging technologies for improving and saving human life. She then joined Columbia University in 2005, where her laboratory hosts the Bioreactor Core of the NIH Center for Tissue Engineering. Dr. Vunjak-Novakovic's research is focused on engineering functional tissues for use as models of diseases, in regenerative medicine, and in studies of stem cells.

Special Guest Speaker Announced

Ken Giacin

We are pleased to announce that Ken Gaicin, Chairman & Chief Executive Officer of StemCyte, Inc., will speak at the upcoming New Jersey Stem Cell Symposium. Prior to joining StemCyte, he held positions as Senior Vice President of Independence Technology at Johnson & Johnson, Corporate Vice President at Church & Dwight/Arm & Hammer, and was Vice President of Johnson & Johnson Baby Products Co.  Mr. Giacin holds both an M.B.A. and an M.S. degree from Rutgers University.  Prior to his career in business, he served as a carrier pilot and officer in the U.S. Navy.